Plazomicin sulfate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for plazomicin sulfate and what is the scope of freedom to operate?
Plazomicin sulfate
is the generic ingredient in one branded drug marketed by Cipla Usa and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Plazomicin sulfate has twenty-eight patent family members in twenty-one countries.
Two suppliers are listed for this compound.
Summary for plazomicin sulfate
| International Patents: | 28 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 6 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for plazomicin sulfate |
| DailyMed Link: | plazomicin sulfate at DailyMed |
US Patents and Regulatory Information for plazomicin sulfate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for plazomicin sulfate
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 2613936 | See Plans and Pricing | |
| Slovenia | 2217610 | See Plans and Pricing | |
| Lithuania | 2217610 | See Plans and Pricing | |
| Croatia | P20170154 | See Plans and Pricing | |
| World Intellectual Property Organization (WIPO) | 2009067692 | See Plans and Pricing | |
| Japan | 2011504508 | See Plans and Pricing | |
| Japan | 4986310 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
